Estimated Half-Life of SARS-CoV-2 Anti-Spike Antibodies More Than Double the Half-Life of Anti-nucleocapsid Antibodies in Healthcare Workers
Jan Van Elslande, Lien Gruwier, Lode Godderis, Pieter Vermeersch
Abstract
sponsorship: Medical Research Council|MR/N00065X/1
Topics & Concepts
MedicineSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibody2019-20 coronavirus outbreakCoronavirus disease 2019 (COVID-19)VirologySpike ProteinImmunologyInternal medicineOutbreakInfectious disease (medical specialty)DiseaseSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingViral Infections and Immunology Research